In vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: increased damage after multiple irradiations N. van (ST) and the vascular effects of photodynamic therapy (PDT) were studied using protoporphyrin IX (PpIX). endogenously generated after i.v. administration of 100 and 200mg kg-' 5-aminolaevulinic acid (ALA). The experimental model was a rat skinfold observation chamber containing a thin layer of ST in which a small syngeneic mammary tumour grows in a sheet-like fashion. Maximum TT and ST fluorescence following 200 mg kg-' ALA was twice the value after 100mg kg-' ALA, but the initial increase with time was the same for the two doses in both TT and ST. The fluorescence increase in ST was slower and the maximum fluorescence was less and appeared later than in TT. Photodynamic therapy was applied using green argon laser light (514.5 nm. 100 J cm -). Three groups received a single light treatment at different intervals after administration of 100 or 200 mg kg-' ALA. In these groups no correlation was found between the fluorescence intensities and the vascular damage following PDT. A fourth group was treated twice and before the second light treatment some fluorescence had reappeared after photobleaching due to the first treatment. Only with the double light treatment was lasting TT necrosis achieved, and for the first time with any photosensitiser in this model this was accomplished without complete ST necrosis.
Photodynamic therapy (PDT) is an experimental cancer treatment modality using photosensitisers that can produce tissue destruction upon absorbing light of an appropriate wavelength and dose. The photosensitiser Photofrin, a derivative of haematoporphyrin, is currently under clinical investigation. Photofrin consists of a mixture of porphyrins, hydrophilic and hydrophobic, which have different fluorescent and photodynamic properties (Kessel, 1982; Dougherty. 1987) . The hydrophilic components fluoresce but are less photodynamically active, whereas the hydrophobic and photodynamically active components generally lack fluorescence. Therefore, the amount of tissue fluorescence after photosensitiser administration is not directly related to the possible PDT effect. Besides this complexity, the major side-effect of Photofrin administration is prolonged photosensitivity of the skin (Dougherty et al., 1990) . These drawbacks have stimulated a search for better photosensitisers for tumour localisation and PDT.
An alternative to administering exogenous photosensitiser is to stimulate cells to generate their own photosensitiser. This can be achieved by 5-aminolaevulinic acid (ALA), which can be converted in situ into protoporphyrin IX (PpIX). ALA is present in all mammalian cells and is the first committed intermediate in the haem biosynthesis pathway. Exogenous ALA bypasses the feedback control, which is regulated by haem, and can therefore induce an intracellular accumulation of PpIX. PpIX is an effective photosensitiser which is associated with the skin phototoxicity seen in patients with porphyria (Jarrett et al., 1956; Shanley et al., 1972) . Animal experiments have shown that after intravenous (i.v.) ALA administration only certain types of tissues manifest PpIX fluorescence (Bedwell et al., 1992; Loh et al., 1992) . This tissue-specific photosensitisation provides a basis for using ALA-induced PpIX for tumour localisation and photodynamic therapy. In contrast to Photofrin, the fluorescence intensity after ALA administration is an indication of the PpIX concentration in tissues (Loh et al., 1993a) . Therefore, fluorescence kinetics can probably be used for determining the optimum interval between ALA administration and light treatment. Another advantage of ALA-induced PpIX is the various possibilities for administration of ALA, besides i.v. Promising results have been obtained in treating basal cell carcinomas using topically applied ALA (Kennedy & Pottier, 1992) . With topical application an enhanced selective effect with PDT can be expected because of the restriction of the induced sensitiser to the lesion and the immediately surrounding normal skin. Loh et al. (1993b) reported selective fluorescence of inoperable rectal adenocarcinomas after oral administration in two patients. Grant et al. (1993) Figure 2a for group A and Figure 2b for Figure 2 ) after treatment for group B, but there was no complete circulation stop. One day after treatment circulation started to recover, and 6 days later hardly any damage remained visible. In both groups studied no distinct selective circulation damage of TT during and after treatment was observed.
Group C was treated at 60 min p.i. using 200 mg kg-' ALA. The vascular damage effects during and after light treatment are shown in Figure 2c . There was hardly any constriction of venules during treatment. The arterioles constricted but emained visible and there was a mild ischaemia in TI. Maximum damage was reached 1 day after treatment, after which the circulation started to recover. There was a selective TI damage but no complete circulation stop was observed.
Group D (200 mg kg-') received two light treatments, at 60 and 150 min p.i. Before and after the treatments fluorescence images were recorded to examine if photobleaching had ocurred during the irradiation and if new fluorescence was formed after the first light treatment. This would indicate the presence of new porphyrin that could be used to increase the effectiveness of PDT. The results of these fluorescence recordings are shown in Figure 3 . The values in this graph were not corrected for background fluorescence. After the first light treatment photobleaching of fluorescence occurred to a level slightly below the autofluorescence intensity. Just before the second light treatment new fluorescence was observed and after treatment it had returned to the mme level as after the first treatment. The vascular damage scores of the two subsequent light treatments are shown in Figure   2d . During the first treatment the same constrction of arterioles (Figure 4b ) occurred as in group C. Before the second treatment constriction in ST and the circulation in TI had recovered to some extent. During the second treatment the same vascular constriction of venules and arterioles was seen as in groups A and B (Figure 4c ). At the end of the second treatment complete stasis of the circulation in TI was observed. The damage to ST on day I was maximal (but not complete) and recovered to some extent, but even after 7 days some areas remained damaged. Necrosis of TI persisted for 7 days, with the exception of one tumour which showed some cirulation at its border 4 days post treatment. In this group the contents of the chamber were retransplantated after 7 days and only two out of six tumours showed regrowth.
Fluorescence kinetic studies
In this study we have examined the fluorescence kinetics of TI and ST after 100 and 200 mg kg-' i.v. adminisered ALA. After both ALA doses the rate of fluorescence increase in TI was higher than in ST. It is known that various malignant tissues have a higher activity of porphobilinogen deaminase (PBGD) and a decreased activity of ferrochelatase (van Hillegersberg et al., 1992) . Therefore, it is likely that the higher rate of fluorescence increase in TI may represent a higher capacity for conversion of ALA to porphyrin or PpIX to haem or a combination of both.
Another explanation for a higher rate of increase in TI may be a higher ALA uptake. However, if ALA uptake determined the rate of fluorescence increase, a steeper rate of increase would be expected after a higher ALA dose. This did not occur, and although maximal fluorescence intensity was twice that after 200 mg kg-' administered ALA, the same maximal rate of increase of fluorescence in both tissues was observed as after 100mg kg-'. As a result, the time to reach maximal fluorescence was longer for the higher ALA dose. This was also found in the normal skin of mice by Pottier et al. (1986) . It may indicate that the limiting factor in the rate of fluorescence increase is the biosynthesis of haem.
An interesting observation is the difference between T[ and ST in the time required to reach maximal fluorescence. Maximal TT fluorescence was reached earlier than maximal ST fluorescence and as a result ST fluorescence was still increasing at a point when TT fluorescence had already decreased. This is not compatible with ALA uptake in TT higher than in ST and with a reduction in ferrochelatase activity in TT. It is likely that i.v. administered ALA is rapidly cleared from the circulation. This results in a strong reduction of available ALA for TT in the course of time. It may be possible that maximal ALA accumulation in cells takes place directly after injection and that ALA, or an intermediate of the haem synthesis, is retained there. As a result, ALA or intermediates in the cell will be depleted faster in 1T owing to the increased PpIX synthesis. This could explain why TT fluorescence started to decrease before ST fluorescence. The difference in maximum fluorescence between 1T and ST may then be explained by a difference in ALA uptake.
We observed no difference in fluorescence kinetics following i.p. or i.v. administered ALA (unpublished data). Loh et al. (1993b) found that the fluorescence kinetics after oral ALA administration was similar to that after i.v. administered ALA, although a higher ALA dose was necessary to achieve the same tissue concentrations of PpIX. Therefore, no difference in fluorescence kinetics after oral ALA administration compared with i.v. is expected to occur in our model. Whether fluorescence kinetics after topical ALA is similar to i.v. ALA will be investigated in this model in future.
Phototherapy studies The vascular effects during and after treatment were examined in four groups of animals differing in ALA dose and interval between ALA administration and light treatment. Treatment time points were chosen based on the observed fluorescence kinetics after 100 and 200mg kg-' ALA. The chambers of the first two groups (A and B) were treated at maximal difference between TT and ST. These experiments were set up to achieve maximal selective TT circulation damage. Therefore, the chambers were treated at maximal difference between TT and ST fluorescence and not at maximal fluorescence.
Despite differences in fluorescence intensities between the two doses of ALA and between TT and ST, no differences in the level of circulation damage could be observed. Furthermore, the overall circulation damage effects were relatively minor, and there was no complete circulation stop in TT. The basis of the apparent discrepancy between the fluor- escence intensities and the lack of photodynamic damage may be the strong vascular constriction during treatment observed after both ALA doses. These vascular effects during treatment are similar to those observed with almost all sensitisers investigated in this model (Star et al., 1986; van Leengoed et al., 1993 ). An optimal oxygen supply during treatment is necessary to obtain tissue damage with PDT (Moan & Sommer, 1985; Henderson & Fingar, 1987) . Therefore, a reduction in tissue oxygenation as a result of vascular shutdown during treatment limits the effectiveness of PDT.
No constriction was observed during treatment at 60 min p.i. with group C (200mgkg-'). This lack of constriction during treatment could be caused by a low capacity of endothelial cells to generate PpIX. Although the fluorescence intensity was less, a larger and a more selective level of TT damage was obtained compared with a treatment at maximal difference in fluorescence between TT and ST. This may have been made possible by the blood supply remaining intact during treatment. The increased selective effects on TT treated at 60 min p.i. could also be the result of translocation within the cell of porphyrin from the mitochondrion to less sensitive sites (Kessel, 1986; Malik & Lugaci, 1987) . Since PpIX is formed in the mitochondrion and because the mitochondrion is very sensitive for PDT damage (Hilf, 1986; Salet, 1986) an increased effect may be expected when treating at an interval where the rate of fluorescence increase is maximal as done in group C.
In summary, in this model no correlation was found between the fluorescence intensity and the level of damage after a single light treatment. As discussed, two factors may determine the level of damage after treatment: the quality of blood supply during treatment and the localisation of PpIX in the cell in the course of time. Based on the results obtained with our experiments the optimal interval for a single light treatment may be early p.i. when the maximal rate of PpIX accumulation is observed and no vascular constriction during treatment seems to occur.
The relative importance of the intracellular localisation of PpIX and the vascular effects during treatment may be deter- (Star et al.. 1986; Leengoed, 1993) , a large area of permanent ST necrosis was necessary to yield permanent TT necrosis. This could indicate an increased fraction of direct tumour cell kill by ALA-PDT, compared for example with PDT using Photofrin, where this fraction is quite small (Henderson & Fingar, 1987) .
During the recovery period of 75 mmn between the end of the first and the beginning of the second treatment the minor constriction caused by the first treatment recovered. After the first light treatment the fluorescence had bleached to a level slightly below the autoflourescence. This could be caused by bleaching of naturally occurring fluorochromes, for example degradation products of chlorophyll present in animal food (Weagle et al., 1988) . However, no photodynamic damage was observed in control animals treated with light alone.
Before the second treatment new fluorescence in TI and ST was observed which was less, in absolute terms, than observed in untreated animals at similar time points. This might indicate that after the first treatment cells were damaged and had therefore lost haem-generating capacity.
Cells that still have that capacity can form new PpIX. Dan et al. (1993) reported about a decreased ferrochelatase activity in cells after a single light treatment. This induced decrease can result in an increase in the rate of PpIX accumulation. These cells may be damaged severely by the second treatment, which might explain the increased damage effects after two subsequent treatments. Another possible explanation for the severe damage effects with two subsequent treatments may be that cells that are damaged by the first treatment will release PpIX. This PpIX may then cause damage to other cells during the second treatment. However this is not likely to occur because complete bleaching after the first treatment was observed.
In conclusion, no direct correlation was found between fluorescence intensity and the amount of vascular damage to TT and ST in this model after i.v. administration of ALA. With a single light treatment no complete circulation stop in TT was obtained. Only with a double treatment could persistent tumour necrosis be obtained without causing complete necrosis of the surrounding subcutaneous tissue.
